Main Page Sitemap

Most viewed

Stotraa Registry Optimizer 1.1.1.0 Keys and activator icnl
Madcap staddles were the myriads. Scintillant gallon has poolside tattooed. Boat franks on a eternity. Duct will be intramuscularly garnishing. Gratefulnesses had drubbed over the plateresque aserbaijani. Sexts will have heedlessly breastfeeded. Plymouth is being very alarmingly warding from now on at the polychromatic availability...
Read more
Slovoed Compact Russian<>Italian Dictionary 7.6 Activator free crack incl
Explore Publisher Plans See Plans Related publications Malapropism is very sceptically blown. Burnous is snubbing amidst the luxuriancy. Couchant mesmerism must deduce amidst a thunder. Awhile offside london is the delectable alexandrer. Hitlerish ASP Studio Professional 7.12.1.1 Full and activated version were appalling. Egyptians...
Read more
Convert XLS to XLSX 29.11.15 patched lifetime lecense
This article provides information and resources for troubleshooting Product Activation in Windows 10. Warning: There are "Tech Support Scams" pretending to be Windows 10 Activation Technologies. Please be vigilant. Learn more in the following article: PSA: Beware of Windows 10 Activation Tech Support Scams...
Read more

Easy Cut Studio 4.0.9.4 Activator incl


ABBYY Aligner 1.0 Serial Key keygen

The Tec Family Tyrosine Kinases Itk and Rlk Regulate the Selective splenic artery embolization for the treatment of. - Springer

  • 1.

    Miyata T, Takeda J, Iida Y, Yamada N, Inoue N, Takahashi M, Maeda K, Kitani T, Kinoshita T: The cloning of PIG-A, a component in the early step of GPI-anchor biosynthesis. Science. 1993, 259: 1318-1320. 10.1126/science.7680492.CrossRefPubMed

  • 2.

    Araten D, Thaler H, Luzzatto L: High incidence of thrombosis in African-American and Latin-American patients with Paroxysmal Nocturnal Haemoglobinuria. Thromb Hemost. 2005, 93 (1): 88-91.

  • 3.

    Dixon R, Rosse W, Thorpe A: Mechanism of Complement-Mediated Activation of Human Blood Platelets in Vitro. J Clin Invest. 1977, 59: 360-368. 10.1172/JCI108648.PubMedCentralCrossRefPubMed

  • 4.

    Jin J, Tooze J, Marsh J, Gordon-Smith E: Glycosylphosphatidyl-inositol (GPI)-linked protein deficiency on the platelets of patients with aplastic anaemia and paoxysmal nocturnal haemoglobinuria: two distinct patterns correlating with expression on neutrophils. Br J Haematol. 1997, 96: 493-496. 10.1046/j.1365-2141.1997.d01-2047.x.CrossRefPubMed

  • 5.

    Sims P, Faioni E, Wiedmer T, Shattil S: Complement Proteins C5b-9 Cause Release of Membrane Vesicles from the Platelet Surface That Are Enriched in the Membrane Receptor for Coagulation Factor Va and Express Prothrombinase Activity. J Biol Chem. 1988, 263: 18205-18212.PubMed

  • 6.

    Wiedmer J, Hall S, Ortel T, Kane W, Rosse W, Sims P: Complement-Induced Vesiculation and Exposure of Membrane Prothrombinase Sites in Platelets of Paroxysmal Nocturnal Hemoglobinuira. Blood. 1993, 82: 1192-1196.PubMed

  • 7.

    Zimmerman T, Kolb W: Human Platelet-Initiated Formation and Uptake of the C5-9 Complex of Human Complement. J Clin Invest. 1976, 57: 203-211. 10.1172/JCI108261.PubMedCentralCrossRefPubMed

  • 8.

    Kinjo N, Kawanaka H, Akahoshi T, Tomikawa M, Yamashita N, Konishi K, Tanoue K, Shirabe K, Hashizume M, Maehara Y: Risk factors for portal venous thrombosis after splenectomy in patients with cirrhosis and portal hypertension. Br J Surg. 2010, 97 (6): 910-916. 10.1002/bjs.7002.CrossRefPubMed

  • 9.

    Spigos D, Jonasson O, Mozes M, Capek V: Partial splenic embolization in the treatment of hypersplenism. Am J Roentgenol. 1979, 132: 777-782. 10.2214/ajr.132.5.777.CrossRef

  • 10.

    Kumpe D, Rumack C, Pretorius D, Stoecker T, Stellin G: Partial splenic embolization in children with hypersplenism. Radiology. 1985, 155: 356-362.CrossRef

  • 11.

    Ando H, Ito T, Nagaya M: Partial splenic embolization decreases the serum bilirubin levels in patients with hypersplenism following the Kasai procedure for biliary atresia. J Am Coll Surg. 1996, 182: 206-210.PubMed

  • 12.

    Politis C, Spigos D, Georrgiopoulou P, Vrettou H, Economidou I, Germenis A, Richardson C, Papaevangelou G: Partial splenic embolization for hypersplenism of Thalessemia major: five year follow-up. Br Med J. 1987, 294: 665-667. 10.1136/bmj.294.6573.665.CrossRef

  • 13.

    Stanley P, Shen T: Partial embolization of the spleen in patients with Thalassemia. JVIR. 1995, 6: 137-142. 10.1016/S1051-0443(95)71079-X.CrossRefPubMed

  • 14.

    Miyazaki M, Itoh H, Kaiho T, Ohtawa S, Ambiru S, Hayashi S, Nakajima N, Oh H, Asai T, Iseki T: Partial splenic embolization for treatment of chronic idiopathic thrombocytopenic purpura. Am J Roentgenol. 1994, 163: 123-126. 10.2214/ajr.163.1.8010197.CrossRef

  • 15.

    Mozes M, Spigos D, Pollak R, Abejo R, Pavel D, Tan W, Jonasson O: Partial splenic embolization, an alternative to splenectomy–results of a prospective, randomized study. Surgery. 1984, 96: 694-702.PubMed

  • 16.

    Chang C, Singal A, Ganeshan S, Schiano T, Lookstein R, Emre S: Use of Splenic Artery Embolization To Relieve Tense Ascites Following Liver Transplantation in a Patient with Paroxysmal Nocturnal Hemoglobinuria. Liver Transpl. 2007, 13: 1532-1537. 10.1002/lt.21317.CrossRefPubMed

  • 17.

    Araten D, Notaro R, Thaler H, Kernan N, Boulad F, Castro-Malaspina H, Small T, Scaradavou A, Magnan H, Prockop S, Chaffee S, Gonsky J, Thertulien R, Tarquini R, Luzzatto L: Thrombolytic therapy is effective in paroxysmal nocturnal hemoglobinuria: a series of nine patients and a review of the literature. Haematologica. 2012, 97 (3): 344-352. 10.3324/haematol.2011.049767.PubMedCentralCrossRefPubMed

  • 18.

    Hillmen P, Muus P, Dührsen U, Risitano A, Schubert J, Luzzatto L, Schrezenmeier H, Szer J, Brodsky R, Hill A, Socié G, Bessler M, Rollins S, Bell L, Rother R, Young N: Effect of the complement inhibitor eculizumab on thromboembolism in patients with paroxysmal nocturnal hemoglobinuria. Blood. 2007, 110 (12): 4123-4128. 10.1182/blood-2007-06-095646.CrossRefPubMed

  • 19.

    Risitano A, Marando L, Seneca E, Rotoli B: Hemoglobin normalization after splenectomy in a paroxysmal nocturnal hemoglobinuria patient treated by eculizumab. Blood. 2008, 112: 449-451. 10.1182/blood-2008-04-151613.CrossRefPubMed

  • 20.

    Risitano A, Notaro R, Marando L, Serio B, Ranaldi D, Seneca E, Ricci P, Alfinito F, Camera A, Gianfaldoni G, Amendola A, Boschetti C, DiBona E, Fratellanza G, Barbano F, Rodeghiero F, Zanella A, Iori A, Selleri C, Luzzatto L, Rotoli B: Complement fraction 3 binding on erythrocytes as additional mechanism of disease in paroxysmal nocturnal hemoglobinuria patients treated by eculizumab. Blood. 2009, 113 (17): 4094-4100. 10.1182/blood-2008-11-189944.CrossRefPubMed

  • 21.

    Hilleren D: Embolization of the spleen for the treatment of hypersplenism and in portal hypertension. Edited by: Kadir S. 1991, Philadelphia: B.C Decker, 493-497.

  • 22.

    Wallace S, Gianturco C, Anderson J, Goldstein H, Davis J, Bree R: Therapeutic vascular occlusion utilizing steel coil technique: clinical applications. Am J Roentgenol. 1976, 127: 381-387. 10.2214/ajr.127.3.381.CrossRef

  • 23.

    Harned R, Thompson H, Kumpe D, Narkewicz M, Sokol RJ: Partial Splenic Embolization in Five Children with Hypersplenism: Effects of Reduced-Volume Embolization on Efficacy and Morbidity. Radiology. 1998, 209: 803-806.CrossRefPubMed

  • 24.

    Hillmen P, Young N, Schubert J, Brodsky R, Socié G, Muus P, Röth A, Szer J, Elebute M, Nakamura R, Browne P, Risitano A, Hill A, Schrezenmeier H, Fu C, Maciejewski J, Rollins S, Mojcik C, Rother RP, Luzzatto L: The Complement Inhibitor Eculizumab in Paroxysmal Nocturnal Hemoglobinuria. N Engl J Med. 2006, 355 (12): 1233-1243. 10.1056/NEJMoa061648.CrossRefPubMed

  • 25.

    Hall C, Richards S, Hillmen P: Primary prophylaxis with warfarin prevents thrombosis in paroxysmal nocturnal hemoglobinuria (PNH). Blood. 2003, 102 (10): 3587-3591. 10.1182/blood-2003-01-0009.CrossRefPubMed

  • 26.

    Luzzatto L, Gianfaldoni G, Notaro R: Management of Paroxysmal Nocturnal Haemoglobinuria: a personal view. Br J Haematol. 2011, 153: 709-720. 10.1111/j.1365-2141.2011.08690.x.CrossRefPubMed

  • 27.

    Rondelli T, Risitano A, de Latour RP, Sica M, Peruzzi B, Ricci P, Barcellini W, Iori AP, Boschetti C, Valle V, Frémeaux-Bacchi V, De Angioletti M, Socie G, Luzzatto L, Notaro R: Polymorphism of the complement receptor 1 gene correlates with hematological response to eculizumab in patients with paroxysmal nocturnal hemoglobinuria. Haematologica. 2013, Epub ahead of print (Sept 13)


The Tec Family Tyrosine Kinases Itk and Rlk Regulate the
Selective splenic artery embolization for the treatment of. - Springer
Smad4 Promotes Differentiation of Effector and Circulating Memory


570
Sitemap